Trials / Completed
CompletedNCT03165851
Efficacy Analysis of Comparison of CAMS（Chinese Academy of Medical Sciences）-2005 Trial and CAMS-2009 Trial for Pediatric Acute Myeloid Leukemia
Efficacy Analysis of Comparison of CAMS-2005 Trial and CAMS-2009 Trial for Pediatric Acute Myeloid Leukemia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 320 (actual)
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China · Academic / Other
- Sex
- All
- Age
- 6 Months – 16 Years
- Healthy volunteers
- Not accepted
Summary
The investigators adopted the CAMS（Chinese Academy of Medical Sciences）-2009 trial for pediatric acute myeloid leukemia (AML) patients between 2009 to 2015, in which a risk-stratified strategy and dose-dense intensive chemotherapy were introduced. The outcomes of CAMS-2009 trial were retrospectively analyzed, and compared to the CAMS-2005 trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Risk-stratified therapy | Dose-dense intensive chemotherapy and high dose of Ara-C in the consolidation therapy. |
Timeline
- Start date
- 2005-04-10
- Primary completion
- 2012-12-31
- Completion
- 2015-12-31
- First posted
- 2017-05-24
- Last updated
- 2026-02-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03165851. Inclusion in this directory is not an endorsement.